Tonix Pharmaceuticals Announces Research Collaboration to Develop Precision Medicine Techniques for COVID-19 Vaccines and Therapeutics
Dissecting the Immune Response to SARS-CoV-2 in Healthy Recovered or Asymptomatic Volunteers May Lead to Biomarkers for Tailoring COVID-19 Vaccines and Therapeutics
Potential for Human Monoclonal Antibody COVID-19 Therapeutics to be Developed as a Result of the Collaboration.
today announced it has entered into a research collaboration and option agreement with Columbia University
The research is designed to fill in important gaps in understanding the detailed immune responses to COVID-19, and to provide a foundation upon which to target vaccines and therapeutics to appropriate individuals by precision medicine.
tonixpharma.com/news-events/press-releases/detail/1215/tonix-pharmaceuticals-announces-research-collaboration-to
alphastocknews.com/tonix-pharmaceuticals-tnxp-stock-rockets-on-covid-19-news/3791/
Dissecting the Immune Response to SARS-CoV-2 in Healthy Recovered or Asymptomatic Volunteers May Lead to Biomarkers for Tailoring COVID-19 Vaccines and Therapeutics
Potential for Human Monoclonal Antibody COVID-19 Therapeutics to be Developed as a Result of the Collaboration.
today announced it has entered into a research collaboration and option agreement with Columbia University
The research is designed to fill in important gaps in understanding the detailed immune responses to COVID-19, and to provide a foundation upon which to target vaccines and therapeutics to appropriate individuals by precision medicine.
tonixpharma.com/news-events/press-releases/detail/1215/tonix-pharmaceuticals-announces-research-collaboration-to
alphastocknews.com/tonix-pharmaceuticals-tnxp-stock-rockets-on-covid-19-news/3791/
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。